ATE122883T1 - Arzneimittel enthaltend ranitidin/wismutcarboxylat-salze. - Google Patents

Arzneimittel enthaltend ranitidin/wismutcarboxylat-salze.

Info

Publication number
ATE122883T1
ATE122883T1 AT92103741T AT92103741T ATE122883T1 AT E122883 T1 ATE122883 T1 AT E122883T1 AT 92103741 T AT92103741 T AT 92103741T AT 92103741 T AT92103741 T AT 92103741T AT E122883 T1 ATE122883 T1 AT E122883T1
Authority
AT
Austria
Prior art keywords
products containing
medicinal products
carboxylate salts
bismuth carboxylate
containing ranitidine
Prior art date
Application number
AT92103741T
Other languages
English (en)
Inventor
Stephen John Douglas
Colin Roy Heppenstall
Norman Richard Smith
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE122883T1 publication Critical patent/ATE122883T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
AT92103741T 1990-09-11 1992-03-05 Arzneimittel enthaltend ranitidin/wismutcarboxylat-salze. ATE122883T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909019875A GB9019875D0 (en) 1990-09-11 1990-09-11 Pharmaceutical compositions
NO920408A NO179694C (no) 1990-09-11 1992-01-30 Farmasöytiske preparater inneholdende ranitidinderivater
PCT/EP1992/000498 WO1993017679A1 (en) 1990-09-11 1992-03-05 Compositions containing ranitidine/bismuth carboxylates salts

Publications (1)

Publication Number Publication Date
ATE122883T1 true ATE122883T1 (de) 1995-06-15

Family

ID=47884627

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0180191A AT405134B (de) 1990-09-11 1991-09-10 Furanderivate enthaltende pharmazeutische präparate
AT92103741T ATE122883T1 (de) 1990-09-11 1992-03-05 Arzneimittel enthaltend ranitidin/wismutcarboxylat-salze.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT0180191A AT405134B (de) 1990-09-11 1991-09-10 Furanderivate enthaltende pharmazeutische präparate

Country Status (33)

Country Link
US (1) US5456925A (de)
EP (1) EP0558779B1 (de)
JP (1) JPH0692849A (de)
KR (1) KR100196308B1 (de)
AT (2) AT405134B (de)
AU (2) AU640816B2 (de)
BE (1) BE1005115A5 (de)
BG (1) BG61931B1 (de)
CA (1) CA2050970C (de)
CH (1) CH683068A5 (de)
CY (1) CY1988A (de)
DE (2) DE4130061A1 (de)
DK (1) DK159191A (de)
ES (1) ES2072647T3 (de)
FI (1) FI944047A (de)
FR (1) FR2666508B1 (de)
GB (2) GB9019875D0 (de)
HK (1) HK60894A (de)
HU (1) HU211846A9 (de)
IE (1) IE65049B1 (de)
IL (1) IL99428A (de)
IT (1) IT1249696B (de)
MX (1) MX9101009A (de)
NL (1) NL194907C (de)
NO (1) NO179694C (de)
NZ (1) NZ239731A (de)
OA (1) OA10093A (de)
RO (1) RO112084B1 (de)
RU (1) RU2108097C1 (de)
SE (1) SE509694C2 (de)
SK (1) SK279591B6 (de)
WO (1) WO1993017679A1 (de)
ZA (1) ZA917176B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
DE69228738D1 (de) * 1991-12-06 1999-04-29 Glaxo Group Ltd Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
US6117412A (en) * 1995-01-26 2000-09-12 Nycomed Imaging As Non-cluster type bismuth compounds
WO2000010562A1 (fr) * 1998-08-18 2000-03-02 Leonidov Nikolai B Forme physiquement stable et amorphe aux rayons x de ranitidine d'hydrochlorure ayant une action anti-ulcere accrue, et procede de production
EP1104673A1 (de) * 1999-11-30 2001-06-06 Bayer Classics Ein Hydrogencarbonat enthaltendes sprengmittelfreies Arzneimittel
KR100412290B1 (ko) * 2001-11-27 2003-12-31 주식회사 동구제약 라니티딘 함유 현탁제 조성물 및 그의 제조방법
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
WO2010011522A1 (en) * 2008-07-21 2010-01-28 Albemarle Corporation High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
CN115697354A (zh) * 2020-06-01 2023-02-03 香港大学 用于治疗sars-cov-2感染的组合物和方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608257A (en) * 1984-01-03 1986-08-26 Board Of Regents For Oklahoma State University Composition and method for treating heat stress
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
EP0282132B1 (de) * 1987-03-09 1992-09-30 The Procter & Gamble Company Zusammensetzungen und ihre Verwendung zur Behandlung von Magen-Darmstörungen
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
CH679582A5 (de) * 1988-07-18 1992-03-13 Glaxo Group Ltd
ES2040307T3 (es) * 1988-10-08 1993-10-16 Dr. R. Pfleger Chemische Fabrik Gmbh Procedimiento para producir un preparado medicamentoso liquido que contiene bismuto.
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
US5013560A (en) * 1989-03-17 1991-05-07 The Procter & Gamble Company Microbially-stable bismuth-containing liquid pharmaceutical suspensions
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
CY1988A (en) 1997-09-05
WO1993017679A1 (en) 1993-09-16
US5456925A (en) 1995-10-10
GB9119284D0 (en) 1991-10-23
NL194907C (nl) 2003-07-04
NO920408L (no) 1993-08-02
ITRM910673A0 (it) 1991-09-10
EP0558779A1 (de) 1993-09-08
RU2108097C1 (ru) 1998-04-10
NO179694B (no) 1996-08-26
SE509694C2 (sv) 1999-02-22
SK279591B6 (sk) 1999-01-11
AT405134B (de) 1999-05-25
AU640816B2 (en) 1993-09-02
FI944047A0 (fi) 1994-09-02
NO920408D0 (no) 1992-01-30
RO112084B1 (ro) 1997-05-30
IT1249696B (it) 1995-03-09
CA2050970A1 (en) 1992-03-12
FI944047A (fi) 1994-09-02
ES2072647T3 (es) 1995-07-16
DK159191D0 (da) 1991-09-10
ATA180191A (de) 1998-10-15
DK159191A (da) 1992-03-12
HU211846A9 (en) 1995-12-28
KR100196308B1 (ko) 1999-06-15
NL9101533A (nl) 1992-04-01
SK106094A3 (en) 1995-02-08
BG99021A (bg) 1995-06-30
GB2248185B (en) 1994-02-02
BG61931B1 (bg) 1998-10-30
OA10093A (en) 1996-12-18
NL194907B (nl) 2003-03-03
SE9102604L (sv) 1992-03-12
GB9019875D0 (en) 1990-10-24
DE4130061A1 (de) 1992-03-12
NO179694C (no) 1996-12-04
JPH0692849A (ja) 1994-04-05
NZ239731A (en) 1993-10-26
ZA917176B (en) 1992-06-24
GB2248185A (en) 1992-04-01
AU8375791A (en) 1992-03-19
CA2050970C (en) 2002-11-19
EP0558779B1 (de) 1995-05-24
BE1005115A5 (fr) 1993-04-27
FR2666508A1 (fr) 1992-03-13
IE913191A1 (en) 1992-04-22
IL99428A (en) 1996-06-18
HK60894A (en) 1994-07-08
SE9102604D0 (sv) 1991-09-10
FR2666508B1 (fr) 1994-02-18
DE69202696D1 (de) 1995-06-29
IE65049B1 (en) 1995-10-04
AU1334792A (en) 1993-10-05
CH683068A5 (fr) 1994-01-14
KR920005984A (ko) 1992-04-27
ITRM910673A1 (it) 1993-03-10
IL99428A0 (en) 1992-08-18
MX9101009A (es) 1992-05-04

Similar Documents

Publication Publication Date Title
ATE122883T1 (de) Arzneimittel enthaltend ranitidin/wismutcarboxylat-salze.
DE69013473T2 (de) Cimetidin enthaltende Arzneimittel.
ATE163849T1 (de) Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
ES2058651T3 (es) Uso derivados de guanidina para la fabricacion de un medicamento con actividad antagonista de npy.
SE8702941D0 (sv) Farmaceutisk, n-acetyl-cysteininnehallande, vattenloslig komposition
DE69108022D1 (de) Arzneimittel.
PH27446A (en) Compound with gastric acid inhibitory effect
DE68900187D1 (de) Pentamidin enthaltende arzneimittel.
DE3869156D1 (de) Fungizide 2-anilinthiazoline.
DK192487A (da) Carbiovasculaere farmaceutiske praeparater, som er egnet til topisk indgivning
NO873385D0 (no) Oksiran-pseudooligosakkarider, fremgangsmaate til deres fremstilling, deres anvendelse og farmasoeytiske preparater.
GB2162746A (en) Antiacidotic medicinal agent

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties